标签：Pharmaceutical • 2025年3月12日 • 评论已关闭
Hangzhou, February 12, 2025 – REACH24H BaiPharm (Ruiou Baiyao (Hangzhou) Pharmaceutical Technology Co., Ltd.) and Accestra Consulting Company (Hangzho…
标签：Pharmaceutical • 2025年1月22日 • 评论已关闭
As 2025 begins, industries worldwide face a rapidly evolving regulatory landscape. Emerging trends, stricter compliance requirements, and new opportun…
标签：Pharmaceutical • 2024年1月10日 • 评论已关闭
Background In 2023, China implemented a range of drug regulations, encompassing various aspects such as active pharmaceutical ingredient (API) registr…
标签：Pharmaceutical • 2023年12月4日 • 评论已关闭
Background Cambodia, Laos, and Myanmar are all heavily reliant on imported pharmaceutical products. A strong economic outlook in Cambodia and the intr…
标签：Pharmaceutical • 2023年11月29日 • 评论已关闭
In Indonesia, Southeast Asia’s largest consumer market, and Vietnam, a country which has seen a significant rise in rates of health insurance co…
标签：Pharmaceutical • 2023年10月16日 • 评论已关闭
At about 6.6% of GDP, Thailand’s healthcare expenditure is relatively high. Accordingly, the market value of pharmaceuticals in Thailand has gro…
标签：Pharmaceutical • 2023年6月29日 • 评论已关闭
To acquire China National Medical Products Administration (NMPA)’s marketing authorization for medical devices, companies need to file or register the…
标签：Pharmaceutical • 2023年6月15日 • 评论已关闭
There have been numerous new regulations put in place since China National Medical Products Administration (NMPA) joined the International Council for…
标签：Pharmaceutical • 2023年5月29日 • 评论已关闭
On Mar. 3, 2023, China Center for Drug Evaluation (CDE) released six Q&As on drug master file (DMF) filing (Q&A No. 1-2) and drug application’…
标签：Pharmaceutical • 2023年5月29日 • 评论已关闭
On Jan. 1, 2023, China National Medical Products Administration (NMPA) started to require that all documents for drug registration applications, as we…
